Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App




Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response

By LabMedica International staff writers
Posted on 20 Oct 2026

The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date. More...

Because many acute febrile illnesses can present with similar symptoms, rapid differential testing is important for identifying suspected cases, guiding patient management, supporting contact tracing, and helping limit transmission.

The BIOFIRE Global Fever Special Pathogens Panel has received Emergency Use Listing (EUL) from the World Health Organization (WHO) to support the current Ebola response. Manufactured by BioFire Defense, a bioMérieux company, the panel detects 16 pathogens from a single whole blood sample in approximately one hour. Targets include multiple Ebola viruses, malaria parasites, Marburg virus, West Nile virus, Lassa virus, and Bundibugyo ebolavirus.

The WHO listing provides an international reference and an accelerated pathway for health authorities, international organizations, and procurement partners to consider the panel for outbreak response and future preparedness. The panel is also cleared by the U.S. Food and Drug Administration and recommended by the U.S. Centers for Disease Control and Prevention for response to the current outbreak.

Since the start of the outbreak, bioMérieux has worked with ministries of health, public health agencies, and local partners to assess diagnostic needs, strengthen laboratory capacity, and support deployment of testing resources across affected regions. The company has expanded manufacturing capacity, accelerated delivery of instruments and assays, and provided training and on-site support for laboratory professionals.

Instruments and reagents have been supplied to the Rwanda Biomedical Centre and Uganda National Health Laboratory Services. Additional systems and tests are also being deployed in the Democratic Republic of the Congo in collaboration with the National Institute for Biomedical Research and national health authorities.

“The WHO Emergency Use Listing is an important milestone for public health preparedness and outbreak response. When an outbreak occurs, early and accurate diagnosis can make the difference between isolated cases and wider transmission. Expanding access to timely differential diagnostics helps healthcare professionals act more quickly, allocate resources more effectively and better protect communities,” said Dr. Charles K. Cooper, Executive Vice President, Chief Medical Officer, bioMérieux.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.